Scholtz & Company’s Global Medical REIT GMRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-290,050
| Closed | -$2.87M | – | 54 |
|
|
2024
Q3 | $2.87M | Buy |
290,050
+138,290
| +91% | +$1.37M | 1.36% | 23 |
|
|
2024
Q2 | $1.38M | Sell |
151,760
-10,340
| -6% | -$93.9K | 0.59% | 31 |
|
|
2024
Q1 | $1.42M | Buy |
162,100
+1,210
| +0.8% | +$10.6K | 0.63% | 31 |
|
|
2023
Q4 | $1.79M | Sell |
160,890
-2,010
| -1% | -$22.3K | 0.88% | 33 |
|
|
2023
Q3 | $1.46M | Sell |
162,900
-1,855
| -1% | -$16.6K | 0.96% | 29 |
|
|
2023
Q2 | $1.5M | Sell |
164,755
-5,255
| -3% | -$48K | 0.94% | 29 |
|
|
2023
Q1 | $1.55M | Sell |
170,010
-194,290
| -53% | -$1.77M | 1.11% | 27 |
|
|
2022
Q4 | $3.45M | Sell |
364,300
-9,100
| -2% | -$86.3K | 2.45% | 13 |
|
|
2022
Q3 | $3.58M | Buy |
373,400
+11,358
| +3% | +$109K | 2.56% | 12 |
|
|
2022
Q2 | $4.07M | Buy |
362,042
+183
| +0.1% | +$2.06K | 2.5% | 14 |
|
|
2022
Q1 | $5.91M | Buy |
361,859
+6,140
| +2% | +$100K | 2.33% | 15 |
|
|
2021
Q4 | $6.31M | Buy |
355,719
+41,791
| +13% | +$742K | 2.04% | 20 |
|
|
2021
Q3 | $4.62M | Buy |
313,928
+15,707
| +5% | +$231K | 1.63% | 25 |
|
|
2021
Q2 | $4.4M | Buy |
298,221
+21,005
| +8% | +$310K | 1.51% | 28 |
|
|
2021
Q1 | $3.63M | Buy |
277,216
+2,755
| +1% | +$36.1K | 1.38% | 29 |
|
|
2020
Q4 | $3.58M | Buy |
274,461
+3,561
| +1% | +$46.5K | 1.4% | 31 |
|
|
2020
Q3 | $3.66M | Buy |
270,900
+47,525
| +21% | +$642K | 1.6% | 22 |
|
|
2020
Q2 | $2.53M | Buy |
+223,375
| New | +$2.53M | 1.26% | 31 |
|
|
2016
Q4 | – | Sell |
-57,500
| Closed | -$561K | – | 42 |
|
|
2016
Q3 | $561K | Buy |
+57,500
| New | +$561K | 0.58% | 32 |
|